Published in Nanoscale on April 16, 2012
Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology (2013) 1.05
CPMV-DOX delivers. Mol Pharm (2012) 1.05
Nanoinformatics: a new area of research in nanomedicine. Int J Nanomedicine (2012) 1.03
Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine. J Biol Phys (2013) 0.94
Interior engineering of a viral nanoparticle and its tumor homing properties. Biomacromolecules (2012) 0.90
Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery. J Control Release (2013) 0.89
Genetically engineered nanocarriers for drug delivery. Int J Nanomedicine (2014) 0.88
Genetic engineering and chemical conjugation of potato virus X. Methods Mol Biol (2014) 0.85
Endocytic uptake pathways utilized by CPMV nanoparticles. Mol Pharm (2012) 0.83
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer (Auckl) (2015) 0.83
Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy. ACS Nano (2016) 0.82
Utilizing Viral Nanoparticle/Dendron Hybrid Conjugates in Photodynamic Therapy for Dual Delivery to Macrophages and Cancer Cells. Bioconjug Chem (2016) 0.79
Viral nanoparticle-encapsidated enzyme and restructured DNA for cell delivery and gene expression. Proc Natl Acad Sci U S A (2014) 0.77
Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chem Soc Rev (2016) 0.77
Active targeted drug delivery for microbes using nano-carriers. Curr Top Med Chem (2015) 0.75
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A (2008) 7.06
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J (2004) 6.90
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol (2000) 6.90
In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int J Pept Protein Res (1993) 5.82
Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther (2007) 5.79
Multifunctional nanocarriers. Adv Drug Deliv Rev (2006) 4.46
Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem (2000) 4.02
Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation. Angew Chem Int Ed Engl (2009) 3.81
Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev (2005) 2.70
Nucleophilic catalysis of oxime ligation. Angew Chem Int Ed Engl (2006) 2.69
Viral nanoparticles as tools for intravital vascular imaging. Nat Med (2006) 2.46
Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano (2008) 2.25
Pathway for polyarginine entry into mammalian cells. Biochemistry (2004) 2.14
Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev (2004) 2.12
Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J Am Chem Soc (2007) 1.98
Multifunctional nanoparticles--properties and prospects for their use in human medicine. Trends Biotechnol (2008) 1.86
Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chem Biol (2007) 1.70
New addresses on an addressable virus nanoblock; uniquely reactive Lys residues on cowpea mosaic virus. Chem Biol (2004) 1.67
Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett (2006) 1.67
Cargo delivery kinetics of cell-penetrating peptides. Biochim Biophys Acta (2001) 1.64
Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol (2005) 1.60
Bisaryl hydrazones as exchangeable biocompatible linkers. Angew Chem Int Ed Engl (2010) 1.59
Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophys J (2006) 1.52
Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. Nano Lett (2007) 1.51
Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. Nanomedicine (Lond) (2011) 1.49
Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. Bioconjug Chem (2007) 1.48
Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog (2009) 1.47
Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett (2010) 1.42
Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug Chem (2005) 1.37
Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nat Protoc (2010) 1.34
Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology (1994) 1.32
Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjug Chem (2007) 1.27
Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int J Nanomedicine (2007) 1.27
Visualisation of macropinosome maturation by the recruitment of sorting nexins. J Cell Sci (2006) 1.25
Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors. Small (2011) 1.22
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol Pharmacol (2002) 1.20
Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur J Pharm Biopharm (2007) 1.20
Nanomedicine: application of nanobiotechnology in medical practice. Med Princ Pract (2008) 1.16
Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer. Langmuir (2007) 1.14
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. J Drug Target (2007) 1.14
Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther (2007) 1.12
A new class of silica cross-linked micellar core-shell nanoparticles. J Am Chem Soc (2006) 1.11
Protein transduction domains: are they delivering? Trends Pharmacol Sci (2003) 1.11
Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system. Integr Biol (Camb) (2010) 1.07
Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo. PLoS One (2009) 1.05
Cowpea mosaic virus as a vaccine carrier of heterologous antigens. Mol Biotechnol (2001) 1.05
Encapsidation of nanoparticles by red clover necrotic mosaic virus. J Am Chem Soc (2007) 1.04
Buckyballs meet viral nanoparticles: candidates for biomedicine. J Am Chem Soc (2009) 1.04
Internalization of novel non-viral vector TAT-streptavidin into human cells. BMC Biotechnol (2007) 1.02
Genome-free viral capsids as carriers for positron emission tomography radiolabels. Mol Imaging Biol (2008) 1.00
High-density targeting of a viral multifunctional nanoplatform to a pathogenic, biofilm-forming bacterium. Chem Biol (2007) 0.99
In vitro-reassembled plant virus-like particles for loading of polyacids. J Gen Virol (2006) 0.97
Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide. Biomed Pharmacother (2008) 0.96
Comovirus isolation and RNA extraction. Methods Mol Biol (1998) 0.95
Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking. Int J Pharm (2007) 0.92
Infusion of dye molecules into Red clover necrotic mosaic virus. Chem Commun (Camb) (2008) 0.92
Endocytosis via caveolae: alternative pathway with distinct cellular compartments to avoid lysosomal degradation? J Cell Mol Med (2009) 0.89
Cell membrane translocation of the N-terminal (1-28) part of the prion protein. Biochem Biophys Res Commun (2002) 0.85
The use of pronase in tissue culture: a comparison with trypsin. J Cell Physiol (1970) 0.81
Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis. J Virol Methods (2007) 0.81
Paclitaxel: epirubicin in metastatic breast cancer--a review. Ann Oncol (2001) 0.80
Comparative metagenomics of microbial communities. Science (2005) 25.88
A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol (2006) 10.14
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A (2005) 3.75
The landscape of C. elegans 3'UTRs. Science (2010) 3.32
A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic (2007) 3.01
A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71
Nucleophilic catalysis of oxime ligation. Angew Chem Int Ed Engl (2006) 2.69
High-efficiency labeling of sialylated glycoproteins on living cells. Nat Methods (2009) 2.46
Nucleophilic catalysis of hydrazone formation and transimination: implications for dynamic covalent chemistry. J Am Chem Soc (2006) 2.45
Context-dependent contributions of backbone hydrogen bonding to beta-sheet folding energetics. Nature (2004) 2.44
Use of qigong therapy in the detoxification of heroin addicts. Altern Ther Health Med (2002) 2.28
Rapid oxime and hydrazone ligations with aromatic aldehydes for biomolecular labeling. Bioconjug Chem (2008) 2.25
Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J Comp Neurol (2007) 2.17
Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. J Infect Dis (2011) 1.98
An efficient Fmoc-SPPS approach for the generation of thioester peptide precursors for use in native chemical ligation. Angew Chem Int Ed Engl (2008) 1.95
Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. J Mol Biol (2006) 1.90
Labeling live cells by copper-catalyzed alkyne--azide click chemistry. Bioconjug Chem (2010) 1.86
Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. J Virol (2003) 1.84
Uptake of a fluorescent marker in plant cells is sensitive to brefeldin A and wortmannin. Plant Cell (2002) 1.83
Plant-derived pharmaceuticals--the road forward. Trends Plant Sci (2005) 1.82
Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci Transl Med (2012) 1.82
Molecular farming in plants: host systems and expression technology. Trends Biotechnol (2003) 1.78
Auxin transport inhibitors impair vesicle motility and actin cytoskeleton dynamics in diverse eukaryotes. Proc Natl Acad Sci U S A (2008) 1.74
Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody. J Virol (2006) 1.71
A sulfilimine bond identified in collagen IV. Science (2009) 1.69
Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates. Nat Mater (2006) 1.66
Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Exp Neurol (2006) 1.64
A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies. J Virol (2009) 1.63
Bisaryl hydrazones as exchangeable biocompatible linkers. Angew Chem Int Ed Engl (2010) 1.59
Fusion proteins comprising a Fusarium-specific antibody linked to antifungal peptides protect plants against a fungal pathogen. Nat Biotechnol (2004) 1.59
GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. J Biol Chem (2009) 1.56
Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev (2008) 1.56
Emphysematous gastritis caused by Sarcina ventriculi. Gastrointest Endosc (2010) 1.54
Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot. J Am Chem Soc (2003) 1.51
Applications of viral nanoparticles in medicine. Curr Opin Biotechnol (2011) 1.49
Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci U S A (2006) 1.46
Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep (2005) 1.45
Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett (2010) 1.42
Structures of the agouti signaling protein. J Mol Biol (2005) 1.42
The controlled display of biomolecules on nanoparticles: a challenge suited to bioorthogonal chemistry. Bioconjug Chem (2011) 1.39
Mouse relapse model of Clostridium difficile infection. Infect Immun (2011) 1.36
Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. Bioconjug Chem (2006) 1.34
Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nat Protoc (2010) 1.34
Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res (2009) 1.32
TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol (2008) 1.31
The art of engineering viral nanoparticles. Mol Pharm (2010) 1.30
Plant cell cultures for the production of recombinant proteins. Nat Biotechnol (2004) 1.27
Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J Neurosci (2005) 1.26
Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. ACS Nano (2011) 1.26
Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol (2005) 1.26
Toward assessing the position-dependent contributions of backbone hydrogen bonding to beta-sheet folding thermodynamics employing amide-to-ester perturbations. J Am Chem Soc (2004) 1.26
Extending synthetic access to proteins with a removable acyl transfer auxiliary. J Am Chem Soc (2002) 1.26
Non-equilibrium allele frequency spectra via spectral methods. Theor Popul Biol (2011) 1.26
Interactions of chronic lead exposure and intermittent stress: consequences for brain catecholamine systems and associated behaviors and HPA axis function. Toxicol Sci (2005) 1.25
Chemical synthesis of a glycoprotein having an intact human complex-type sialyloligosaccharide under the Boc and Fmoc synthetic strategies. J Am Chem Soc (2007) 1.24
Rapid CT diagnosis of acute appendicitis with IV contrast material. Emerg Radiol (2005) 1.22
Unexpected deposition patterns of recombinant proteins in post-endoplasmic reticulum compartments of wheat endosperm. Plant Physiol (2004) 1.22
A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Infect Immun (2012) 1.22
Simultaneous occurrence of Hodgkin's lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging. Clin Lymphoma (2002) 1.21
Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport (2008) 1.21
Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem (2006) 1.20
Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology (2009) 1.19
Preliminary X-ray analysis of a human V(H) fragment at 1.8 A resolution. Acta Crystallogr D Biol Crystallogr (2004) 1.18
Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. Trends Biotechnol (2008) 1.18
Transgenic plants in the biopharmaceutical market. Expert Opin Emerg Drugs (2005) 1.18
Endosperm-specific co-expression of recombinant soybean ferritin and Aspergillus phytase in maize results in significant increases in the levels of bioavailable iron. Plant Mol Biol (2005) 1.17
Multifunctional compact zwitterionic ligands for preparing robust biocompatible semiconductor quantum dots and gold nanoparticles. J Am Chem Soc (2011) 1.16
Histopathological correlates of magnetic resonance imaging-defined chronic perinatal white matter injury. Ann Neurol (2011) 1.15
Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides. Bioconjug Chem (2008) 1.15
Quantum-dot/dopamine bioconjugates function as redox coupled assemblies for in vitro and intracellular pH sensing. Nat Mater (2010) 1.15
Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum Mol Genet (2006) 1.15
International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging (2010) 1.14
The structure of the dizinc subclass B2 metallo-beta-lactamase CphA reveals that the second inhibitory zinc ion binds in the histidine site. Antimicrob Agents Chemother (2009) 1.14
Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J (2007) 1.13
Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene. J Biol Chem (2004) 1.13
Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X. Mol Pharm (2012) 1.13
Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent. JACC Cardiovasc Imaging (2009) 1.12
Polyphenoloxidase silencing affects latex coagulation in Taraxacum species. Plant Physiol (2009) 1.11
Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. Virology (2008) 1.11
Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents. J Mater Chem B Mater Biol Med (2013) 1.10
Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness. Am J Hum Genet (2005) 1.10
Potato virus X as a novel platform for potential biomedical applications. Nano Lett (2010) 1.08
Large-area compliant tactile sensors using printed carbon nanotube active-matrix backplanes. Adv Mater (2015) 1.07
Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system. Integr Biol (Camb) (2010) 1.07
Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design. Proc Natl Acad Sci U S A (2013) 1.07
Spatial and temporal regulation of the forisome gene for1 in the phloem during plant development. Plant Mol Biol (2007) 1.06
Correlating gene expression variation with cis-regulatory polymorphism in Saccharomyces cerevisiae. Genome Biol Evol (2010) 1.06
Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots. Cancer Res (2008) 1.06
An unusual internal ribosomal entry site of inverted symmetry directs expression of a potato leafroll polerovirus replication-associated protein. Proc Natl Acad Sci U S A (2003) 1.06
Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnol J (2008) 1.05
CPMV-DOX delivers. Mol Pharm (2012) 1.05
Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. Antioxid Redox Signal (2013) 1.04
Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus. Nano Lett (2014) 1.04
Synthetic seleno-glutaredoxin 3 analogues are highly reducing oxidoreductases with enhanced catalytic efficiency. J Am Chem Soc (2006) 1.04
Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan. Neurotox Res (2009) 1.04